NYSE Arca · IHE

iShares U.S. Pharmaceuticals ETF (IHE)

$103.19+0.64%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$103.19▲ 46.04% in range
Sep 29, 2025Low $70.66 · High $108.16Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

iShares U.S. Pharmaceuticals ETF closed at $103.19 on Sep 28, up 0.64%, 4.6% below its 52-week closing high. Volume of 69.7K shares was 0.44× its 20-day average (below normal).

Split-adjusted performance: -1.5% over one month, +23.2% over six months, +49.4% over one year.

Short interest was 334.0K shares at the Sep 15 settlement, down 20.0% from the prior report (2.0 days to cover).

Market cap$1.68B16.3M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield1.08%$0.2789 last paid
52-week range69.09 – 108.16−4.6% from high
Volume69.7K0.44× 20-day avg
Volatility · 60d17.6%Annualised
Short % of float—2.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +0.9%1M −1.5%3M +3.1%6M +23.2%YTD +21.6%1Y +49.4%3Y +70.0%5Y +67.3%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short334.0K−20.0% vs prior
Days to cover2.0Settled Sep 15
% of float—
Short vol. 10d33.1%of daily volume

Quick answers

What is IHE's market cap?
$1.68B, based on the Sep 28 close of $103.19.
Does iShares U.S. Pharmaceuticals ETF pay a dividend?
Yes. The latest regular dividend was $0.2789 per share (ex-date Sep 15), an annualised yield of 1.08%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology